@rup_mayer

PostDoc @IMP @viennabiocenter in proteomics and single cell proteomics. Previously worked on immunopeptidomics and chronic lymphocytic leukemia.

 Vienna, Austria
Joined August 2022
  • Tweets15
  • Following73
  • Followers55
Rupert Mayer retweeted
MSAID
@msaid_de19 Mar 2024
We are thrilled to announce our upcoming webinar, which delves into the revolutionary impact of CHIMERYS on proteomics through wide-window acquisition and advanced data analysis. Our guest speakers from the IMP (Research Institute of Molecular Pathology) will provide invaluable insights into their experiences and collaborative advancements in the field. 📅 Date: April 9, 2024 ⏱️ Time: 5:00 pm CEST 🔗 Register here for free: events.teams.microsoft.com/e… #TeamProteomics #TeamMassSpec #Proteomics #MassSpectrometry
4
1
6
1,491
The Vienna BioCenter PhD program in Molecular BioSciences will offer 30 fully-funded positions in the Spring Call which opens today. Please RT. Further details: vbcphd.at @IMPvienna @IMBA_Vienna @gmivienna @MaxPerutzLabs @univienna @MedUni_Wien
29
4
67
13,221
Rupert Mayer retweeted
Cellenion@Cellenion15 Nov 2023
Today, we’re proud to announce the launch of our latest solution for Single Cell Proteomics: proteoCHIP EVO 96. Place your first order before 31st March and get the Accessory Kit for free: lnkd.in/ekmKaa7w Learn more: lnkd.in/eFc79xyW #proteomics @EvosepBio
3
15
5,911
We are very happy to announce that our latest story was published in @ScienceMagazine yesterday! 🥳🎉 science.org/doi/10.1126/scie… (1/6)

Decrypting drug actions and protein modifications by dose- and time-resolved proteomics

Dose-dependent effects of drugs on post-translational modifications reveal insights into their actions.

science.org
5
82
3
321
44,085
Rupert Mayer retweeted
Cellenion@Cellenion23 Feb 2023
New Application Note! Cardiomyocyte isolation using Cellenion’s cellenONE® instrument To read the application note, click here: lnkd.in/eAM8nx43 #singlecell #isolation #cardiomyocyte #proteomics #transcriptomics
1
1
369
Rupert Mayer retweeted
Impens Lab@ImpensLab17 Oct 2022
Finally published! Thank you all co-authors for their priceless contribution! Here we designed mRNA vaccine formulations against Listeria using immunopeptidomics Looking forward to continue our efforts to tackle other intracellular bacterial pathogens tinyurl.com/vaccineListeria
3
18
1
48
Rupert Mayer retweeted
IMP@IMPvienna4 Oct 2022
Scientists at our Protein Chemistry facility successfully established a loss-free single cell #proteomics workflow reaching outstanding proteome depth. Congrats to @m_matzinger, @Elisabe99796418 et al! biorxiv.org/content/10.1101/…

Robust and easy-to-use one pot workflow for label free single cell proteomics

The analysis of ultra-low input samples or individual cells is critical for answering a multitude of biomedical questions. But current proteomic workflows are limited in their sensitivity and...

biorxiv.org
5
2
Very interesting tool about #rescoring in #immunopeptidomics! We are excited to try it out @RalfGabriels mcponline.org/article/S1535-…

MS2Rescore: Data-Driven Rescoring Dramatically Boosts Immunopeptide Identification Rates

In BriefThe integration of newly trained immunopeptide MS2PIP models, DeepLC, and Percolator into one software package called MS2Rescore allows for a significant boost in immunopeptide identification...

mcponline.org
1
3
10
Rupert Mayer retweeted
Cellenion@Cellenion22 Sep 2022
We are proud to announce that our cellenONE online training course is now available for our customers and users on the Cellenion Academy! Register now! lnkd.in/eqZFFSYU #training #learning #cellenONE #singlecell
3
4
Rupert Mayer retweeted
Impens Lab@ImpensLab23 Aug 2022
biorxiv.org/content/10.1101/… #Immunopeptidomics #AntigenDiscovery #Listeria #BacterialPathogens #MassSpec #VIB #UGent

Immunopeptidomics-based design of highly effective mRNA vaccine formulations against Listeria...

Listeria monocytogenes is a foodborne intracellular bacterial pathogen leading to human listeriosis. Despite a high mortality rate and increasing antibiotic resistance no clinically approved vaccine...

biorxiv.org
1
2
Rupert Mayer retweeted
Impens Lab@ImpensLab23 Aug 2022
@ugent @VIBLifeSciences @VIB_CMB @FWOVlaanderen
1
Rupert Mayer retweeted
Impens Lab@ImpensLab23 Aug 2022
Very happy to share our work on mRNA vaccine formulations against Listeria MS and immunopeptidomics hold great promise to uncover antigens for next-generation vaccines, especially for intracellular bacteria. Incredibly grateful to all co-authors for their dedication and efforts!
2
7
16
Load more